OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,270,000 | +112.5% | 224,723 | +51.0% | 0.00% | 0.0% |
| Q4 2018 | $2,009,000 | +31.8% | 148,788 | +8.4% | 0.00% | 0.0% |
| Q3 2018 | $1,524,000 | +335.4% | 137,298 | +92.7% | 0.00% | – |
| Q4 2016 | $350,000 | +525.0% | 71,245 | +535.2% | 0.00% | – |
| Q3 2016 | $56,000 | -88.7% | 11,216 | -87.1% | 0.00% | – |
| Q1 2016 | $495,000 | -78.4% | 86,700 | -60.6% | 0.00% | -100.0% |
| Q4 2015 | $2,287,000 | -26.6% | 220,311 | +30.7% | 0.00% | 0.0% |
| Q3 2015 | $3,114,000 | -13.8% | 168,620 | -9.2% | 0.00% | -50.0% |
| Q2 2015 | $3,612,000 | -34.6% | 185,625 | -40.9% | 0.00% | 0.0% |
| Q1 2015 | $5,522,000 | -38.1% | 314,111 | -43.7% | 0.00% | -33.3% |
| Q4 2014 | $8,916,000 | +222.9% | 557,555 | +154.2% | 0.00% | +200.0% |
| Q3 2014 | $2,761,000 | -25.7% | 219,364 | -7.8% | 0.00% | -50.0% |
| Q2 2014 | $3,718,000 | -23.5% | 238,022 | -35.7% | 0.00% | +100.0% |
| Q1 2014 | $4,861,000 | -25.6% | 370,219 | -8.9% | 0.00% | -75.0% |
| Q4 2013 | $6,532,000 | +67.8% | 406,185 | +73.6% | 0.00% | +100.0% |
| Q3 2013 | $3,892,000 | +137.0% | 233,925 | +43.5% | 0.00% | +100.0% |
| Q2 2013 | $1,642,000 | – | 163,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|